Related Experiment Videos
[Rat multiple organ failure model caused by zymosan injections: a pathomorphological study]
1304th Hospital of People's Liberation Army, Beijing.
Researchers created a new model of multiple organ failure in rats by injecting them with a substance called Zymosan. This study tracked the physical and chemical changes in the animals to better understand how organs fail during severe illness. By comparing these rats to a healthy control group, the team identified specific patterns of damage that could help doctors diagnose similar conditions in the future. The findings provide a clearer picture of how organ systems break down over time. This work helps bridge the gap between laboratory experiments and clinical understanding of complex systemic diseases.
Area of Science:
- Pathophysiology research involving Zymosan induced organ injury
- Veterinary medicine and experimental pathology
Background:
No established animal model perfectly replicates the complex progression of human multiple organ failure. Prior research has shown that systemic inflammation often precedes the collapse of vital physiological systems. That uncertainty drove the need for a reliable, reproducible experimental platform to study these cascading events. It was already known that certain chemical triggers could induce widespread inflammatory responses in rodent subjects. This gap motivated the development of a standardized protocol using specific biological agents. Investigators previously struggled to capture the full spectrum of cellular and subcellular damage during acute failure. That lack of detailed pathomorphological data hindered the creation of accurate diagnostic criteria for severe systemic conditions. This study addresses those limitations by characterizing the sequential breakdown of organ function in a controlled environment.
Purpose Of The Study:
The aim of this research was to develop a reliable Wistar rat model of multiple organ failure. Investigators sought to establish a reproducible method for studying the progression of systemic inflammatory damage. This problem persists because existing models often fail to capture the full scope of cellular and subcellular pathology. The researchers were motivated by the need to create a platform for diagnosing complex conditions like disseminated intravascular coagulation. They intended to link functional physiological declines with observable tissue changes at the microscopic level. This study addresses the lack of standardized diagnostic criteria for different stages of systemic collapse. By utilizing Zymosan as a trigger, the team aimed to induce a consistent response across their experimental subjects. Their goal was to provide a clear, pathomorphological framework that could assist in future clinical and experimental research.
Main Methods:
The review approach involved a controlled study design using eighty Wistar rats. Investigators divided these subjects into an experimental cohort and a healthy control group. The team administered intraperitoneal injections to induce the desired systemic response. They performed serial sacrifices on days one, two, four, and five to collect necessary samples. The researchers examined blood specimens at each interval to track physiological shifts. They integrated functional assessments with cellular and subcellular pathological evaluations. The team also conducted histochemical analyses to characterize tissue damage at different stages. This systematic strategy ensured a comprehensive overview of the progression of systemic dysfunction.
Main Results:
The experimental group exhibited significant changes in PaO2, GPT, and Cr levels compared to the control subjects. These biochemical shifts indicate a rapid decline in respiratory, hepatic, and renal performance. The researchers observed clinical symptoms including lethargy, hyporeaction, and alimentary tract hemorrhage in the treated animals. Their data show that these physiological markers correlate with the severity of the induced systemic condition. The team successfully mapped these functional changes to specific cellular and subcellular pathological features. They identified distinct patterns of tissue degradation that correspond to the progression of the failure. These findings provide a clear link between systemic inflammatory triggers and multi-organ damage. The results demonstrate that the model consistently produces the intended pathological outcomes for further investigation.
Conclusions:
The authors propose that their model successfully replicates the systemic collapse observed in severe multiple organ failure. Their findings suggest that specific biochemical markers correlate with distinct stages of tissue degradation. The researchers indicate that integrating functional data with cellular pathology improves diagnostic accuracy for disseminated intravascular coagulation. This synthesis implies that the observed physiological shifts reflect a predictable, progressive decline in organ health. The team highlights that their histochemical observations provide a framework for identifying early warning signs of systemic failure. Their work suggests that the progression of damage is measurable through standard blood analysis and tissue examination. The authors conclude that this approach offers a robust tool for future investigations into systemic inflammatory responses. These results imply that standardized models are necessary for developing effective interventions against complex organ dysfunction.
Frequently Asked Questions
The researchers propose that intraperitoneal injections of Zymosan trigger a systemic inflammatory cascade. This leads to significant alterations in oxygen levels, liver enzyme activity, and kidney filtration rates compared to the control group.
The team utilized Wistar rats to evaluate the progression of systemic failure. They monitored these subjects over several days, contrasting their physiological status against a healthy control population.
The authors suggest that examining blood specimens on alternating days is necessary to capture the dynamic shifts in organ function. This frequency allows for the detection of rapid changes in metabolic and respiratory markers.
The researchers employed blood gas analysis, liver enzyme testing, and creatinine measurements to quantify organ impairment. These data types provide a comprehensive view of respiratory, hepatic, and renal health during the failure process.
The team measured PaO2, GPT, and Cr levels to assess the severity of systemic damage. These markers showed significant deviations in the experimental group compared to the stable values found in the control group.
The authors propose that their detailed pathomorphological findings provide a basis for diagnosing disseminated intravascular coagulation at various stages. They suggest this classification system could improve clinical recognition of the condition.